Skip to main content

Table 3 Sensitivity and specificity of Sickle SCAN™ compared to known patient genotypes

From: Validation of a novel point of care testing device for sickle cell disease

 

Sensitivity (95 % CI)

Specificity (95 % Cl)

SCD (HbSS, HbSC, HbSβ+-thal, HbSβ0-thal)

100 % (91–100)

100 % (90–100)

Sickle trait (HbAS)

100 % (85–100)

98 % (90–100)

C trait (HbAC)

100 % (44–100)

100 % (95–100)

Normal (HbAA)

100 % (68–100)

100 % (94–100)